Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise

Current Pharmaceutical Design

Volumn 22, Issue 21, 2016, Pages 3237-3264

  Sharma, Charu ^a   Al Kaabi, Juma M ^a   Nurulain, Syed M ^b   Goyal, Sameer N ^c   Kamal, Mohammad Amjad ^d,e   Ojha, Shreesh ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b Department of Electrical Computer Engineering   (Pakistan)

^c R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

^d KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^e Enzymoics   (Australia)

Author keywords

AM630; CB2 receptor agonist; CB2 receptors; Dietary phytocannabinoids; Phytochemicals; PPAR isoforms; Trans Caryophyllene; Caryophyllene

Indexed keywords

CANNABINOID; CARYOPHYLLENE; HERBACEOUS AGENT; INSECTICIDE; LOCAL ANESTHETIC AGENT; CANNABINOID 2 RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SESQUITERPENE; TOLL LIKE RECEPTOR;

AGING; ALCOHOLISM; ALZHEIMER DISEASE; ANXIETY DISORDER; AREA UNDER THE CURVE; ARTICLE; ATHEROSCLEROSIS; BRAIN ISCHEMIA; DEGENERATIVE DISEASE; DEPRESSION; DIABETES MELLITUS; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; DYSMENORRHEA; ENDOMETRIOSIS; EPILEPSY; GASTROINTESTINAL DISEASE; HUMAN; HYPERPIGMENTATION; HYPERTRIGLYCERIDEMIA; INFECTION; INFLAMMATION; KIDNEY DISEASE; LIPOPHILICITY; LIVER DISEASE; LOCAL ANESTHESIA; LONGEVITY; MALIGNANT NEOPLASTIC DISEASE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; MEDICINAL CHEMISTRY; NEUROPATHIC PAIN; NONHUMAN; PAIN; PARASITOSIS; PARKINSON DISEASE; PEPTIC ULCER; PEST MANAGEMENT; PHYSICAL CHEMISTRY; POLYPHARMACOLOGY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SKIN IRRITATION; SPASMODIC PAIN; TIME TO MAXIMUM PLASMA CONCENTRATION; ULCERATIVE COLITIS; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; CONFORMATION; METABOLISM; STEREOISOMERISM; SYNTHESIS;

ANIMALS; HUMANS; MOLECULAR CONFORMATION; POLYPHARMACOLOGY; PPAR GAMMA; PPAR-BETA; RECEPTOR, CANNABINOID, CB2; SESQUITERPENES; STEREOISOMERISM; TOLL-LIKE RECEPTORS;

EID: 84975763949     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612822666160311115226     Document Type: Article

References (281)

1. de Almeida Borges VR, Ribeiro AF, de Souza Anselmo C, Cabral LM, de Sousa VP. Development of a high performance liquid chromatography method for quantification of isomers betacaryophyllene and alpha-humulene in copaiba oleoresin using the Box-Behnken design. J Chromatogr B Analyt Technol Biomed Life Sci 2013; 940: 35-41.
2. Sales DS, Carmona F, de Azevedo BC, et al. Eugenia punicifolia (Kunth) DC. as an adjuvant treatment for type-2 diabetes mellitus: a non-controlled, pilot study. Phytother Res 2014; 28: 1816-21.
3. Khani A, Heydarian M. Fumigant and repellent properties of sesquiterpene-rich essential oil from Teucrium polium subsp. capitatum (L.). Asian Pac J Trop Med 2014; 7: 956-61.
4. Ricci D, Fraternale D, Giamperi L, et al. Chemical composition, antimicrobial and antioxidant activity of the essential oil of Teucrium marum (Lamiaceae). J Ethnopharmacol 2005; 98: 195-200.
5. Ghelardini C, Galeotti N, Di Cesare Mannelli L, Mazzanti G, Bartolini A. Local anaesthetic activity of beta-caryophyllene. Farmaco 2001; 56(5-7): 387-9.
6. Gertsch J, Leonti M, Raduner S, et al. Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci USA 2008; 105(26): 9099-104.
7. Bhatia SP, Letizia CS, Api AM. Fragrance material review on betacaryophyllene alcohol. Food Chem Toxicol 2008; 46(suppl 11): S95-6.
8. de Groot WN, Weyland JW, Nater JP. Unwanted Effects of Cosmetics and Drugs used in Dermatology. 3rd ed. USA: Elsevier 2015.
9. Skold M, Karlberg AT, Matura M, Borje A. The fragrance chemical beta-caryophyllene-air oxidation and skin sensitization. Food Chem Toxicol 2006; 44(4): 538-45.
10. Opdyke DL. Monographs on fragrance raw materials. Food Cosmet Toxicol 1973; 11: 1011-81.
11. Gertsch J. Anti-inflammatory cannabinoids in diet: Towards a better understanding of CB(2) receptor action? Commun Integr Biol 2008; 1: 26-8.
12. Donati M, Mondin A, Chen Z, et al. Radical scavenging and antimicrobial activities of Croton zehntneri, Pterodon emarginatus and Schinopsis brasiliensis essential oils and their major constituents: estragole, trans-anethole, beta-caryophyllene and myrcene. Nat Prod Res 2015; 29: 939-46.
13. Sain S, Naoghare PK, Devi SS, et al. Beta caryophyllene and caryophyllene oxide, isolated from Aegle marmelos, as the potent anti-inflammatory agents against lymphoma and neuroblastoma cells. Antiinflamm Antiallergy Agents Med Chem: United Arab Emirates 2014; 13(1): 45-55.
14. Hendriks H, Malingré TM, Batterman S, Bos R. Mono-and sesquiterpene hydrocarbons of the essential oil of Cannabis sativa. Phytochemistry 1975; 14: 814-5.
15. Horvath B, Mukhopadhyay P, Kechrid M, et al. beta-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner. Free Radic Biol Med 2012; 52(8): 1325-33.
16. Calleja MA, Vieites JM, Montero-Melendez T, Torres MI, Faus MJ, Gil A, Suarez A. The antioxidant effect of beta-caryophyllene protects rat liver from carbon tetrachloride-induced fibrosis by inhibiting hepatic stellate cell activation. Br J Nutr 2013; 109(3): 394-401.
17. Alva M, Popich S, Borkosky S, Cartagena E, Bardon A. Bioactivity of the essential oil of an argentine collection of Acanthospermum hispidum (Asteraceae). Nat Prod Commun 2012; 7: 245-8.
18. Chai L, Lin CZ, Zhu CC, Zhao ZX, Zhang CX. [Analysis of the chemical constituents of essential oil from the leaves of Callicarpa integerrima]. Zhong Yao Cai 2010; 33: 382-5.
19. Thang TD, Dai do N, Luong NX, Ogunwande IA. Constituents of essential oils from the leaves, stem barks and resins of Canarium parvum Leen., and Canarium tramdenanum Dai et Yakovl. (Burseracea) grown in Vietnam. Nat Prod Res 2014; 28: 461-6.
20. Kobayashi C, Fontanive TO, Enzweiler BG, et al. Pharmacological evaluation of Copaifera multijuga oil in rats. Pharm Biol 2011; 49: 306-13.
21. Veiga Junior VF, Rosas EC, Carvalho MV, Henriques MG, Pinto AC. Chemical composition and anti-inflammatory activity of copaiba oils from Copaifera cearensis Huber ex Ducke, Copaifera reticulata Ducke and Copaifera multijuga Hayne--a comparative study. J Ethnopharmacol 2007; 112: 248-54.
22. Doria GA, Silva WJ, Carvalho GA, Alves PB, Cavalcanti SC. A study of the larvicidal activity of two Croton species from northeastern Brazil against Aedes aegypti. Pharm Biol 2010; 48: 615-20.
23. Rojas J, Baldovino S, Vizcaya M, Rojas LB, Morales A. The chemical composition of the essential oils of Euphorbia caracasana and E. cotinifolia (Euphorbiaceae) from Venezuela. Nat Prod Commun 2009; 4: 571-2.
24. Venturi CR, Danielli LJ, Klein F, et al. Chemical analysis and in vitro antiviral and antifungal activities of essential oils from Glechon spathulata and Glechon marifolia. Pharm Biol 2015; 53: 682-8.
25. Magalhaes LA, Lima Mda P, Marques MO, Facanali R, Pinto AC, Tadei WP. Chemical composition and larvicidal activity against Aedes aegypti larvae of essential oils from four Guarea species. Molecules 2010; 15: 5734-41.
26. Menezes Pdos P, Araujo AA, Doria GA, et al. Physicochemical characterization and analgesic effect of inclusion complexes of essential oil from Hyptis pectinata L. Poit leaves with betacyclodextrin. Curr Pharm Biotechnol 2015; 16: 440-50.
27. de Sousa EO, Rodrigues FF, Campos AR, Lima SG, da Costa JG. Chemical composition and synergistic interaction between aminoglycosides antibiotics and essential oil of Lantana montevidensis Briq. Nat Prod Res 2013; 27: 942-5.
28. Joshi RK. GC/MS analysis of the essential oil of Leucas indica from India. Nat Prod Commun 2014; 9: 1607-8.
29. Joshi RK. Leucas aspera (Willd.) Link Essential Oil from India: beta-Caryophyllene and 1-Octen-3-ol Chemotypes. J Chromatogr Sci. 2015 Nov 29. pii: bmv173.
30. Duarte Moreira RR, Zimmermann Martins G, Teixeira Botelho V, et al. Composition and activity against oral pathogens of the essential oil of Melampodium divaricatum (Rich.) DC. Chem Biodivers 2014; 11: 438-44.
31. Lebouvier N, Lawes D, Hnawia E, Page M, Brophy J, Nour M. The leaf, wood and bark oils of three species of Myodocarpus (Myodocarpaceae) endemic to New Caledonia. Nat Prod Commun 2014; 9: 1223-7.
32. Rodriguez EJ, Ramis-Ramos G, Heyden YV, et al. Chemical composition, antioxidant properties and antimicrobial activity of the essential oil of Murraya paniculata leaves from the mountains of Central Cuba. Nat Prod Commun 2012; 7: 1527-30.
33. Kang W, Li Y, Xu Y, Jiang W, Tao Y. Characterization of aroma compounds in Chinese bayberry (Myrica rubra Sieb. et Zucc.) by gas chromatography mass spectrometry (GC-MS) and olfactometry (GC-O). J Food Sci 2012; 77: C1030-5.
34. Olounlade PA, Azando EV, Hounzangbe-Adote MS, et al. In vitro anthelmintic activity of the essential oils of Zanthoxylum zanthoxyloides and Newbouldia laevis against Strongyloides ratti. Parasitol Res 2012; 110: 1427-33.
35. Ogunwande IA, Walker TM, Bansal A, Setzer WN, Essien EE. Essential oil constituents and biological activities of Peristrophe bicalyculata and Borreria verticillata. Nat Prod Commun 2010; 5: 1815-8.
36. Mohamadi M, Shamspur T, Mostafavi A. Comparison of the essential oil content and composition of the spathe, buds and pollen of Phoenix dactylifera. Nat Prod Res 2014; 28: 205-7.
37. Koutsaviti K, Giatropoulos A, Pitarokili D, Papachristos D, Michaelakis A, Tzakou O. Greek Pinus essential oils: larvicidal activity and repellency against Aedes albopictus (Diptera: Culicidae). Parasitol Res 2015; 114: 583-92.
38. Jirovetz L, Buchbauer G, Ngassoum MB, Geissler M. Aroma compound analysis of Piper nigrum and Piper guineense essential oils from Cameroon using solid-phase microextraction-gas chromatography, solid-phase microextraction-gas chromatographymass spectrometry and olfactometry. J Chromatogr A 2002; 976: 265-75.
39. Orav A, Stulova I, Kailas T, Müürisepp M. Effect of storage on the essential oil composition of Piper nigrum L. fruits of different ripening states. J Agric Food Chem 2004; 52(9): 2582-6.
40. Nikolić M, Stojkovi_ D, Glamočlija J, et al. Could essential oils of green and black pepper be used as food preservatives?. J Food Sci Technol 2015; 52(10): 6565-73.
41. Moura do Carmo DF, Amaral AC, Machado GM, Leon LL, Silva JR. Chemical and biological analyses of the essential oils and main constituents of Piper species. Molecules 2012; 17(2): 1819-29.
42. Padalia RC, Verma RS. Comparative study of volatile oil compositions of two Plectranthus species from northern India. Nat Prod Res 2011; 25: 1727-32.
43. Crevelin EJ, Caixeta SC, Dias HJ, et al. Antimicrobial activity of the essential oil of plectranthus neochilus against cariogenic bacteria. Evid Based Complement Alternat Med 2015; 2015: 102317.
44. Ozturk M, Duru ME, Aydogmus-Ozturk F, et al. GC-MS analysis and antimicrobial activity of essential oil of Stachys cretica subsp. smyrnaea. Nat Prod Commun 2009; 4: 109-14.
45. Boligon AA, Schwanz TG, Piana M, et al. Chemical composition and antioxidant activity of the essential oil of Tabernaemontana catharinensis A. DC. leaves. Nat Prod Res 2013; 27: 68-71.
46. Bezic N, Vuko E, Dunkic V, Ruscic M, Blazevic I, Burcul F. Antiphytoviral activity of sesquiterpene-rich essential oils from four croatian teucrium species. Molecules 2011; 16: 8119-29.
47. Hammami S, El Mokni R, Faidi K, et al. Chemical composition and antioxidant activity of essential oil from aerial parts of Teucrium flavum L. subsp. flavum growing spontaneously in Tunisia. Nat Prod Res 2015: 1-5.
48. Formisano C, Napolitano F, Rigano D, Arnold NA, Piozzi F, Senatore F. Essential oil composition of Teucrium divaricatum Sieb. ssp. villosum (Celak.) Rech. fil. growing wild in Lebanon. J Med Food 2010; 13: 1281-5.
49. Taherpour AA, Maroofi H, Bajelani O, Larijani K. Chemical composition of the essential oil of Valeriana alliariifolia Adams of Iran. Nat Prod Res 2010; 24: 973-8.
50. Joshi RK. Chemical composition of Vernonia albicans essential oil from India. Nat Prod Commun 2014; 9: 997-8.
51. Souza Barbosa PC, Moreira Wiedemann LS, da Silva Medeiros R, de Tarso Barbosa Sampaio P, Vieira G, Florencio da Veiga-Junior V. Phytochemical fingerprints of copaiba oils (Copaifera multijuga Hayne) determined by multivariate analysis. Chem Biodivers 2013; 10: 1350-60.
52. Tholl D, Kish CM, Orlova I, et al. Formation of monoterpenes in Antirrhinum majus and Clarkia breweri flowers involves heterodimeric geranyl diphosphate synthases. Plant Cell 2004; 16: 977-92.
53. Nikolić B, Ristić M, Bojović S, Krivošej Z, Matevski V, Marin PD. Population variability of essential oils of Pinus heldreichii from the Scardo-Pindic mountains Ošljak and Galićica. Chem Biodivers 2015; 12(2): 295-308.
54. Lucca LG, de Matos SP, Borille BT, et al. Determination of betacaryophyllene skin permeation/retention from crude copaiba oil (Copaifera multijuga Hayne) and respective oil-based nanoemulsion using a novel HS-GC/MS method. J Pharm Biomed Anal 2015; 104: 144-8.
55. Soares DC, Portella NA, Ramos MF, Siani AC, Saraiva EM. Transbeta-Caryophyllene: An Effective Antileishmanial Compound Found in Commercial Copaiba Oil (Copaifera spp.). Evid Based Complement Alternat Med 2013; 2013: 761323.
56. Dias Dde O, Colombo M, Kelmann RG, et al. Optimization of headspace solid-phase microextraction for analysis of betacaryophyllene in a nanoemulsion dosage form prepared with copaiba (Copaifera multijuga Hayne) oil. Anal Chim Acta 2012; 721: 79-84.
57. Budavari S, O'Neil M, Smith A, Heckelman P, Obenchain J. The Merck Index, Print Version. Twelfth ed. USA: CRC Press 1996.
58. Richter A, Seidl-Adams I, Kollner TG, Schaff C, Tumlinson JH, Degenhardt J. A small, differentially regulated family of farnesyl diphosphate synthases in maize (Zea mays) provides farnesyl diphosphate for the biosynthesis of herbivore-induced sesquiterpenes. Planta 2015; 241: 1351-61.
59. Yu ZX, Wang LJ, Zhao B, et al. Progressive Regulation of Sesquiterpene Biosynthesis in Arabidopsis and Patchouli (Pogostemon cablin) by the miR156-Targeted SPL Transcription Factors. Mol Plant 2015; 8(1): 98-110.
60. Robert CA, Erb M, Hiltpold I, et al. Genetically engineered maize plants reveal distinct costs and benefits of constitutive volatile emissions in the field. Plant Biotechnol J 2013; 11: 628-39.
61. Sultana N, Saify ZS. Enzymatic biotransformation of terpenes as bioactive agents. J Enzyme Inhib Med Chem 2013; 28: 1113-28.
62. Huang X, Xiao Y, Kollner TG, et al. Identification and characterization of (E)-beta-caryophyllene synthase and alpha/betapinene synthase potentially involved in constitutive and herbivoreinduced terpene formation in cotton. Plant Physiol Biochem 2013; 73: 302-8.
63. Oda S, Fujinuma K, Inoue A, Ohashi S. Synthesis of (-)-betacaryophyllene oxide via regio-and stereoselective endocyclic epoxidation of beta-caryophyllene with Nemania aenea SF 10099-1 in a liquid-liquid interface bioreactor (L-L IBR). J Biosci Bioeng 2011; 112(6): 561-5.
64. Matarese F, Cuzzola A, Scalabrelli G, D'Onofrio C. Expression of terpene synthase genes associated with the formation of volatiles in different organs of Vitis vinifera. Phytochemistry 2014; 105: 12-24.
65. Yahyaa M, Tholl D, Cormier G, Jensen R, Simon PW, Ibdah M. Identification and characterization of terpene synthases potentially involved in the formation of volatile terpenes in carrot (Daucus carota L.) roots. J Agric Food Chem 2015; 63(19): 4870-8.
66. Asakawa Y, Ishida T, Toyota M, Takemoto T. Terpenoid biotransformation in mammals. IV Biotransformation of (+)-longifolene, (-)-caryophyllene, (-)-caryophyllene oxide, (-)-cyclocolorenone, (+)-nootkatone, (-)-elemol, (-)-abietic acid and (+)-dehydroabietic acid in rabbits. Xenobiotica 1986; 16: 753-67.
67. Liu H, Yang G, Tang Y, Cao D, Qi T, Qi Y, Fan G. Physicochemical characterization and pharmacokinetics evaluation of beta-caryophyllene/beta-cyclodextrin inclusion complex. Int J Pharm 2013; 450: 304-10.
68. Vinholes J, Rudnitskaya A, Goncalves P, Martel F, Coimbra MA, Rocha SM. Hepatoprotection of sesquiterpenoids: a quantitative structure-activity relationship (QSAR) approach. Food Chem 2014; 146: 78-84.
69. Chicca A, Caprioglio D, Minassi A, et al. Functionalization of betacaryophyllene generates novel polypharmacology in the endocannabinoid system. ACS Chem Biol 2014; 9: 1499-507.
70. Jung JI, Kim EJ, Kwon GT, et al. beta-Caryophyllene potently inhibits solid tumor growth and lymph node metastasis of B16F10 melanoma cells in high-fat diet-induced obese C57BL/6N mice. Carcinogenesis 2015; 36(9): 1028-39.
71. Bento AF, Marcon R, Dutra RC, Claudino RF, Cola M, Leite DF, Calixto JB. beta-Caryophyllene inhibits dextran sulfate sodiuminduced colitis in mice through CB2 receptor activation and PPARgamma pathway. Am J Pathol 2011; 178(3): 1153-66.
72. Felder CC, Joyce KE, Briley EM, et al. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 1995; 48(3): 443-50.
73. Wu C, Jia Y, Lee JH, Jun HJ, Lee HS, Hwang KY, Lee SJ. trans-Caryophyllene is a natural agonistic ligand for peroxisome proliferator-activated receptor-α. Bioorg Med Chem Lett 2014; 24(14): 3168-74.
74. Lee W, Ham J, Kwon HC, Kim YK, Kim SN. Anti-diabetic effect of amorphastilbol through PPARα/γ dual activation in db/db mice. Biochem Biophys Res Commun. 2013; 432(1): 73-9.
75. Guo K, Mou X, Huang J, Xiong N, Li H. Trans-caryophyllene suppresses hypoxia-induced neuroinflammatory responses by inhibiting NF-kappaB activation in microglia. J Mol Neurosci 2014; 54: 41-8.
76. Kota BP, Huang TH, Roufogalis BD. An overview on biological mechanisms of PPARs. Pharmacol Res 2005; 51(2): 85-94.
77. Inagaki T, Dutchak P, Zhao G, et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab 2007; 5(6): 415-25.
78. O'Sullivan SE1, Kendall DA. Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease. Immunobiology 2010; 215(8): 611-6.
79. Paula-Freire LI, Andersen ML, Gama VS, Molska GR, Carlini EL. The oral administration of trans-caryophyllene attenuates acute and chronic pain in mice. Phytomedicine 2014; 21: 356-62.
80. Katsuyama S, Mizoguchi H, Kuwahata H, et al. Involvement of peripheral cannabinoid and opioid receptors in beta-caryophylleneinduced antinociception. Eur J Pain 2013; 17: 664-75.
81. Galdino PM, Nascimento MV, Florentino IF, et al. The anxiolyticlike effect of an essential oil derived from Spiranthera odoratissima A. St. Hil. leaves and its major component, beta-caryophyllene, in male mice. Prog Neuropsychopharmacol Biol Psychiatry 2012; 38: 276-84.
82. Vinholes J, Goncalves P, Martel F, Coimbra MA, Rocha SM. Assessment of the antioxidant and antiproliferative effects of sesquiterpenic compounds in in vitro Caco-2 cell models. Food Chem 2014; 156: 204-11.
83. Molina-Jasso D, Alvarez-Gonzalez I, Madrigal-Bujaidar E. Clastogenicity of beta-caryophyllene in mouse. Biol Pharm Bull 2009; 32(3): 520-2.
84. Alvarez-Gonzalez I, Madrigal-Bujaidar E, Castro-Garcia S. Antigenotoxic capacity of beta-caryophyllene in mouse, and evaluation of its antioxidant and GST induction activities. J Toxicol Sci 2014; 39: 849-59.
85. Hammami S, El Mokni R, Faidi K, et al. Chemical composition and antioxidant activity of essential oil from aerial parts of Teucrium flavum L. subsp. flavum growing spontaneously in Tunisia. Nat Prod Res 2015; 29(24): 2336-40.
86. Babu RO, Moorkoth D, Azeez S, Eapen SJ. Virtual screening and in vitro assay of potential drug like inhibitors from spices against Glutathione-S-Transferase of Meloidogyne incognita. Bioinformation 2012; 8(7): 319-25.
87. Assis LC, Straliotto MR, Engel D, Hort MA, Dutra RC, de Bem AF. beta-Caryophyllene protects the C6 glioma cells against glutamate-induced excitotoxicity through the Nrf2 pathway. Neuroscience 2014; 279: 220-31.
88. Rufino AT, Ribeiro M, Sousa C, et al. Evaluation of the antiinflammatory, anti-catabolic and pro-anabolic effects of Ecaryophyllene, myrcene and limonene in a cell model of osteoarthritis. Eur J Pharmacol 2015; 750: 141-50.
89. Ma L, Jia J, Liu X, Bai F, Wang Q, Xiong L. Activation of murine microglial N9 cells is attenuated through cannabinoid receptor CB2 signaling. Biochem Biophys Res Commun 2015; 458: 92-7.
90. Fine PG, Rosenfeld MJ. The endocannabinoid system, cannabinoids, and pain. Rambam Maimonides Med J 2013; 4(4): e0022.
91. Fiorenzani P, Lamponi S, Magnani A, Ceccarelli I, Aloisi AM. In vitro and in vivo characterization of the new analgesic combination Beta-caryophyllene and docosahexaenoic Acid. Evid Based Complement Alternat Med 2014; 2014: 596312.
92. Zheng X, Sun T, Wang X. Activation of type 2 cannabinoid receptors (CB2R) promotes fatty acid oxidation through the SIRT1/PGC-1alpha pathway. Biochem Biophys Res Commun 2013; 436: 377-81.
93. Klauke AL, Racz I, Pradier B, et al. The cannabinoid CB(2) receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain. Eur Neuropsychopharmacol 2014; 24: 608-20.
94. Al Mansouri S, Ojha S, Al Maamari E, Al Ameri M, Nurulain SM, Bahi A. The cannabinoid receptor 2 agonist, beta-caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice. Pharmacol Biochem Behav 2014; 124: 260-8.
95. Suijun W, Zhen Y, Ying G, Yanfang W. A role for transcaryophyllene in the moderation of insulin secretion. Biochem Biophys Res Commun 2014; 444: 451-4.
96. Choi IY, Ju C, Anthony Jalin AM, Lee da I, Prather PL, Kim WK. Activation of cannabinoid CB2 receptor-mediated AMPK/CREB pathway reduces cerebral ischemic injury. Am J Pathol 2013; 182: 928-39.
97. Gertsch J. Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system. Planta Med 2008; 74: 638-50.
98. Okoye FB, Osadebe PO, Nworu CS, Okoye NN, Omeje EO, Esimone CO. Topical anti-inflammatory constituents of lipophilic leaf fractions of Alchornea floribunda and Alchornea cordifolia. Nat Prod Res 2011; 25: 1941-9.
99. Medeiros R, Passos GF, Vitor CE, et al. Effect of two active compounds obtained from the essential oil of Cordia verbenacea on the acute inflammatory responses elicited by LPS in the rat paw. Br J Pharmacol 2007; 151(5): 618-27.
100. Menezes Pdos P, Araujo AA, Doria GA, et al. Physicochemical characterization and analgesic effect of inclusion complexes of essential oil from Hyptis pectinata L. Poit leaves with betacyclodextrin. Curr Pharm Biotechnol 2015; 16: 440-50.
101. Ku CM, Lin JY. Anti-inflammatory effects of 27 selected terpenoid compounds tested through modulating Th1/Th2 cytokine secretion profiles using murine primary splenocytes. Food Chem 2013; 141: 1104-13.
102. Galiegue S, Mary S, Marchand J, et al. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 1995; 232: 54-61.
103. Choi JS, Park C, Jeong JW. AMP-activated protein kinase is activated in Parkinson's disease models mediated by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Biochem Biophys Res Commun 2010; 391: 147-51.
104. Gowran A, Noonan J, Campbell VA. The multiplicity of action of cannabinoids: implications for treating neurodegeneration. CNS Neurosci Ther 2011; 17: 637-44.
105. Fernandez-Ruiz J, Moreno-Martet M, Rodriguez-Cueto C, et al. Prospects for cannabinoid therapies in basal ganglia disorders. Br J Pharmacol 2011; 163: 1365-78.
106. Zoppi S, Madrigal JL, Caso JR, et al. Regulatory role of the cannabinoid CB2 receptor in stress-induced neuroinflammation in mice. Br J Pharmacol 2014; 171: 2814-26.
107. Pacher P, Mackie K. Interplay of cannabinoid 2 (CB2) receptors with nitric oxide synthases, oxidative and nitrative stress, and cell death during remote neurodegeneration. J Mol Med (Berl) 2012; 90: 347-51.
108. Chang HJ, Kim JM, Lee JC, Kim WK, Chun HS. Protective effect of beta-caryophyllene, a natural bicyclic sesquiterpene, against cerebral ischemic injury. J Med Food 2013; 16: 471-80.
109. Chang HJ, Kim HJ, Chun HS. Quantitative structure-activity relationship (QSAR) for neuroprotective activity of terpenoids. Life Sci 2007; 80: 835-41.
110. Elmann A, Mordechay S, Rindner M, Larkov O, Elkabetz M, Ravid U. Protective Effects of the Essential Oil of Salvia fruticosa and Its Constituents on Astrocytic Susceptibility to Hydrogen Peroxide-Induced Cell Death. J Agric Food Chem 2009; 57: 6636-41.
111. Bonesi M, Menichini F, Tundis R, et al. Acetylcholinesterase and butyrylcholinesterase inhibitory activity of Pinus species essential oils and their constituents. J Enzyme Inhib Med Chem 2010; 25: 622-8.
112. Murata K, Matsumura S, Yoshioka Y, Ueno Y, Matsuda H. Screening of beta-secretase and acetylcholinesterase inhibitors from plant resources. J Nat Med 2015; 69: 123-9.
113. Cheng Y, Dong Z, Liu S. beta-Caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 Mice through CB2 receptor activation and the PPARgamma pathway. Pharmacology 2014; 94: 1-12.
114. Anavi-Goffer S, Gertsch J. Treatment of schizophrenia using betacaryophyllene and cb2 receptor agonists, WO 2013140342 A1; PCT/IB2013/052182; Publication Date: 26 September 2013.
115. Aso E, Ferrer I. Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic. Front Pharmacol 2014; 5: 37.
116. Jiang L, Role LW. Facilitation of cortico-amygdala synapses by nicotine: activity-dependent modulation of glutamatergic transmission. J Neurophysiol 2008; 99: 1988-99.
117. Parri HR, Hernandez CM, Dineley KT. Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease. Biochem Pharmacol 2011; 82: 931-42.
118. King JR, Nordman JC, Bridges SP, Lin MK, Kabbani N. Identification and characterization of a G protein-binding cluster in alpha7 nicotinic acetylcholine receptors. J Biol Chem 2015.
119. Siddique YH, Naz F, Jyoti S, et al. Effect of centella asiatica leaf extract on the dietary supplementation in transgenic drosophila model of Parkinson's disease. Parkinsons Dis 2014; 2014: 262058.
120. dos Santos RG, Hallak JE, Leite JP, Zuardi AW, Crippa JA. Phytocannabinoids and epilepsy. J Clin Pharm Ther 2015; 40: 135-43.
121. Liu H, Song Z, Liao D, et al. Neuroprotective effects of transcaryophyllene against kainic acid induced seizure activity and oxidative stress in mice. Neurochem Res 2015; 40: 118-23.
122. Zarruk JG, Fernandez-Lopez D, Garcia-Yebenes I, et al. Cannabinoid type 2 receptor activation downregulates strokeinduced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection. Stroke 2012; 43: 211-9.
123. Molina-Holgado E, Vela JM, Arevalo-Martin A, et al. Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling. J Neurosci 2002; 22: 9742-53.
124. Ashton JC, Glass M. The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration. Curr Neuropharmacol 2007; 5: 73-80.
125. Murikinati S, Juttler E, Keinert T, et al. Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment. FASEB J 2010; 24: 788-98.
126. Suzuki N, Suzuki M, Hamajo K, Murakami K, Tsukamoto T, Shimojo M. Contribution of hypothermia and CB1 receptor activation to protective effects of TAK-937, a cannabinoid receptor agonist, in rat transient MCAO model. PLoS One 2012; 7: e40889.
127. Micale V, Di Marzo V, Sulcova A, Wotjak CT, Drago F. Endocannabinoid system and mood disorders: priming a target for new therapies. Pharmacol Ther 2013; 138: 18-37.
128. Bahi A, Al Mansouri S, Al Memari E, Al Ameri M, Nurulain SM, Ojha S. beta-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice. Physiol Behav 2014; 135: 119-24.
129. Vasiljevik T, Franks LN, Ford BM, et al. Design, synthesis, and biological evaluation of aminoalkylindole derivatives as cannabinoid receptor ligands with potential for treatment of alcohol abuse. J Med Chem 2013; 56: 4537-50.
130. Basavarajappa BS. The endocannabinoid signaling system: a potential target for next-generation therapeutics for alcoholism. Mini Rev Med Chem 2007; 7: 769-79.
131. Baylac S, Racine P. Inhibition of 5-lipoxygenase by essential oils and other natural fragrant extracts. Int J Aromatherapy 2003; 96: 138-42.
132. Merfort I. Perspectives on sesquiterpene lactones in inflammation and cancer. Curr Drug Targets 2011; 12: 1560-73.
133. Anand P, Whiteside G, Fowler CJ, Hohmann AG. Targeting CB2 receptors and the endocannabinoid system for the treatment of pain. Brain Res Rev 2009; 60: 255-66.
134. Ligresti A, Martos J, Wang J, et al. Prostamide F(2) alpha receptor antagonism combined with inhibition of FAAH may block the proinflammatory mediators formed following selective FAAH inhibition. Br J Pharmacol 2014; 171: 1408-19.
135. Whiteside TL. The role of death receptor ligands in shaping tumor microenvironment. Immunol Invest 2007; 36: 25-46.
136. Guindon J, Hohmann AG. Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. Br J Pharmacol 2008; 153: 319-34.
137. Hsieh YH, McCartney K, Moore TA, et al. Intestinal ischemiareperfusion injury leads to inflammatory changes in the brain. Shock 2011; 36: 424-30.
138. Luongo L, Maione S, Di Marzo V. Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoidneurotrophin interactions. Eur J Neurosci 2014; 39: 401-8.
139. Wang D, Couture R, Hong Y. Activated microglia in the spinal cord underlies diabetic neuropathic pain. Eur J Pharmacol 2014; 728: 59-66.
140. Gui H, Tong Q, Qu W, Mao CM, Dai SM. The endocannabinoid system and its therapeutic implications in rheumatoid arthritis. Int Immunopharmacol 2015; 26: 86-91.
141. Ray K. Rheumatoid arthritis: Clue to role of cannabinoid receptors in RA. Nat Rev Rheumatol 2014; 10: 128.
142. Fukuda S, Kohsaka H, Takayasu A, et al. Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis. BMC Musculoskelet Disord 2014; 15: 275.
143. Rom S, Persidsky Y. Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation. J Neuroimmune Pharmacol 2013; 8: 608-20.
144. Gertsch J, Raduner S, Altmann KH. New natural noncannabinoid ligands for cannabinoid type-2 (CB2) receptors. J Recept Signal Transduct Res 2006; 26(5-6): 709-30.
145. Agarwal RB, Rangari VD. Phytochemical investigation and evaluation of anti-inflammatory and anti-arthritic activities of essential oil of Strobilanthus ixiocephala Benth. Indian J Exp Biol 2003; 41: 890-4.
146. Fernandes ES, Passos GF, Medeiros R, et al. Anti-inflammatory effects of compounds alpha-humulene and (-)-trans-caryophyllene isolated from the essential oil of Cordia verbenacea. Eur J Pharmacol 2007; 569: 228-36.
147. Camara CC, Nascimento NR, Macedo-Filho CL, Almeida FB, Fonteles MC. Antispasmodic effect of the essential oil of Plectranthus barbatus and some major constituents on the guineapig ileum. Planta Med 2003; 69: 1080-5.
148. Leonhardt V, Leal-Cardoso JH, Lahlou S, et al. Antispasmodic effects of essential oil of Pterodon polygalaeflorus and its main constituent beta-caryophyllene on rat isolated ileum. Fundam Clin Pharmacol 2010; 24(6): 749-58.
149. Ojo JO, Rezaie P, Gabbott PL, Stewart MG. Impact of age-related neuroglial cell responses on hippocampal deterioration. Front Aging Neurosci 2015; 7: 57.
150. Pant A, Saikia SK, Shukla V, Asthana J, Akhoon BA, Pandey R. Beta-caryophyllene modulates expression of stress response genes and mediates longevity in Caenorhabditis elegans. Exp Gerontol 2014; 57: 81-95.
151. Izzo AA, Coutts AA. Cannabinoids and the digestive tract. Handb Exp Pharmacol 2005: 573-98.
152. Di Sabatino A, Battista N, Biancheri P, et al. The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease. Mucosal Immunol 2011; 4: 574-83.
153. Tourteau A, Andrzejak V, Body-Malapel M, et al. 3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis. Bioorg Med Chem 2013; 21: 5383-94.
154. Singh UP, Singh NP, Singh B, Price RL, Nagarkatti M, Nagarkatti PS. Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis. Toxicol Appl Pharmacol 2012; 258: 256-67.
155. Slebioda TJ, Kmiec Z. Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease. Mediatiors Inflamm 2014; 2014: 325129.
156. Cho JY, Chang HJ, Lee SK, Kim HJ, Hwang JK, Chun HS. Amelioration of dextran sulfate sodium-induced colitis in mice by oral administration of beta-caryophyllene, a sesquiterpene. Life Sci 2007; 80(10): 932-9.
157. Celinski K, Dworzanski T, Fornal R, et al. Comparison of antiinflammatory properties of peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone in prophylactic treatment of experimental colitis. J Physiol Pharmacol 2013; 64: 587-95.
158. Annese V, Rogai F, Settesoldi A, Bagnoli S. PPARgamma in inflammatory bowel disease. PPAR Res 2012; 2012: 620839.
159. Nieto-Bobadilla MS, Siepmann F, Djouina M, et al. Controlled delivery of a new broad spectrum antibacterial agent against colitis: In vitro and in vivo performance. Eur J Pharm Biopharm 2015; 96: 152-61.
160. Lau JY, Barkun A, Fan DM, Kuipers EJ, Yang YS, Chan FK. Challenges in the management of acute peptic ulcer bleeding. Lancet 2013; 381: 2033-43.
161. Tambe Y, Tsujiuchi H, Honda G, Ikeshiro Y, Tanaka S. Gastric cytoprotection of the non-steroidal anti-inflammatory sesquiterpene, beta-caryophyllene. Planta Med 1996; 62: 469-70.
162. Wright MB, Bortolini M, Tadayyon M, Bopst M. Minireview: Challenges and opportunities in development of PPAR agonists. Mol Endocrinol 2014; 28: 1756-68.
163. Lefterova MI, Haakonsson AK, Lazar MA, Mandrup S. PPARgamma and the global map of adipogenesis and beyond. Trends Endocrinol Metab 2014; 25: 293-302.
164. Kim HL, Jeon YD, Park J, et al. Corni fructus containing formulation attenuates weight gain in mice with diet-induced obesity and regulates adipogenesis through AMPK. Evid Based Complement Alternat Med 2013; 2013: 423741.
165. Li C, Bowe JE, Jones PM, Persaud SJ. Expression and function of cannabinoid receptors in mouse islets. Islets 2010; 2: 293-302.
166. Basha RH, Sankaranarayanan C. beta-Caryophyllene, a natural sesquiterpene, modulates carbohydrate metabolism in streptozotocin-induced diabetic rats. Acta Histochem 2014; 116: 1469-79.
167. O'Sullivan SE. Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. Br J Pharmacol 2007; 152: 576-82.
168. Stanley C, O'Sullivan SE. Vascular targets for cannabinoids: animal and human studies. Br J Pharmacol 2014; 171: 1361-78.
169. Aghamohammadi A, Hosseinimehr SJ. Antiangiogenic agents in natural products for the treatment of gynecologic disorders. Nutr Cancer 2014; 66: 206-13.
170. Munoz-Hernando L, Munoz-Gonzalez JL, Marqueta-Marques L, et al. Endometriosis: alternative methods of medical treatment. Int J Womens Health 2015; 7: 595-603.
171. Sanchez-Munoz BA, Aguilar MI, King-Diaz B, Rivero JF, Lotina-Hennsen B. The sesquiterpenes beta-caryophyllene and caryophyllene oxide isolated from Senecio salignus act as phytogrowth and photosynthesis inhibitors. Molecules 2012; 17(2): 1437-47.
172. Dmitrieva N, Nagabukuro H, Resuehr D, et al. Endocannabinoid involvement in endometriosis. Pain 2010; 151: 703-10.
173. Sasaki M, Hashimoto S, Sawa T, Amaya F. Tumor necrosis factoralpha induces expression of C/EBP-beta in primary afferent neurons following nerve injury. Neuroscience 2014; 279: 1-9.
174. Leconte M, Nicco C, Ngo C, et al. Antiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis. Am J Pathol 2010; 177: 2963-70.
175. McHugh D, Page J, Dunn E, Bradshaw HB. Delta(9)-Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells. Br J Pharmacol 2012; 165: 2414-24.
176. McHugh D. GPR18 in microglia: implications for the CNS and endocannabinoid system signalling. Br J Pharmacol 2012; 167: 1575-82.
177. Abbas MA, Taha MO, Zihlif MA, Disi AM. beta-Caryophyllene causes regression of endometrial implants in a rat model of endometriosis without affecting fertility. Eur J Pharmacol 2013; 702: 12-9.
178. Ou MC, Hsu TF, Lai AC, Lin YT, Lin CC. Pain relief assessment by aromatic essential oil massage on outpatients with primary dysmenorrhea: a randomized, double-blind clinical trial. J Obstet Gynaecol Res 2012; 38: 817-22.
179. Legault J, Pichette A. Potentiating effect of beta-caryophyllene on anticancer activity of alpha-humulene, isocaryophyllene and paclitaxel. J Pharm Pharmacol 2007; 59: 1643-7.
180. Amiel E, Ofir R, Dudai N, Soloway E, Rabinsky T, Rachmilevitch S. beta-Caryophyllene, a compound isolated from the biblical balm of gilead (commiphora gileadensis), is a selective apoptosis inducer for tumor cell lines. Evid Based Complement Alternat Med 2012; 2012: 872394.
181. Chavan MJ, Wakte PS, Shinde DB. Analgesic and antiinflammatory activity of Caryophyllene oxide from Annona squamosa L. bark. Phytomedicine 2010; 17: 149-51.
182. da Silva KA, Paszcuk AF, Passos GF, et al. Activation of cannabinoid receptors by the pentacyclic triterpene alpha,betaamyrin inhibits inflammatory and neuropathic persistent pain in mice. Pain 2011; 152(8): 1872-87.
183. Zhang W, Lim LY. Effects of spice constituents on P-glycoproteinmediated transport and CYP3A4-mediated metabolism in vitro. Drug Metab Dispos 2008; 36(7): 1283-90.
184. Tundis R, Loizzo MR, Bonesi M, et al. In vitro cytotoxic effects of Senecio stabianus Lacaita (Asteraceae) on human cancer cell lines. Nat Prod Res 2009; 23(18): 1707-18.
185. Gowda PJ, Ramakrishnaiah H, Krishna V, Narra S, Jagannath N. Caryophyllene-rich essential oil of Didymocarpus tomentosa: chemical composition and cytotoxic activity. Nat Prod Commun 2012; 7: 1535-8.
186. do NFJE, Ferraz RP, Britto AC, et al. Antitumor effect of the essential oil from leaves of Guatteria pogonopus (Annonaceae). Chem Biodivers 2013; 10: 722-9.
187. Costa EV, Menezes LR, Rocha SL, et al. Antitumor Properties of the Leaf Essential Oil of Zornia brasiliensis. Planta Med 2015; 81: 563-7.
188. Zheng GQ, Kenney PM, Lam LK. Sesquiterpenes from clove (Eugenia caryophyllata) as potential anticarcinogenic agents. J Nat Prod 1992; 55: 999-1003.
189. Kubo I, Chaudhuri SK, Kubo Y, et al. Cytotoxic and antioxidative sesquiterpenoids from Heterotheca inuloides. Planta Med 1996; 62: 427-30.
190. Loizzo MR, Tundis R, Menichini F, Saab AM, Statti GA. Antiproliferative effects of essential oils and their major constituents in human renal adenocarcinoma and amelanotic melanoma cells. Cell Prolif 2008; 41(6): 1002-12.
191. Fraternale D, Albertini MC, Rudov A, et al. Compton: Trichomes, essential oil constituents and cytotoxic-apoptotic activity. Nat Prod Res 2013; 27: 1583-8.
192. Su YC, Hsu KP, Wang EI, Ho CL. Composition and in vitro anticancer activities of the leaf essential oil of Neolitsea variabillima from Taiwan. Nat Prod Commun 2013; 8: 531-2.
193. Lampronti I, Saab AM, Gambari R. Antiproliferative activity of essential oils derived from plants belonging to the Magnoliophyta division. Int J Oncol 2006; 29: 989-95.
194. Chang CC, Hsu HF, Huang KH, et al. Anti-proliferative effects of Siegesbeckia orientalis ethanol extract on human endometrial RL-95 cancer cells. Molecules 2014; 19(12): 19980-94.
195. Shirazi MT, Gholami H, Kavoosi G, Rowshan V, Tafsiry A. Chemical composition, antioxidant, antimicrobial and cytotoxic activities of Tagetes minuta and Ocimum basilicum essential oils. Food Sci Nutr 2014; 2: 146-55.
196. Capello TM, Martins EG, de Farias CF, et al. Chemical composition and in vitro cytotoxic and antileishmanial activities of extract and essential oil from leaves of Piper cernuum. Nat Prod Commun 2015; 10(2): 285-8.
197. Campos MI, Vieira WD, Campos CN, Aarestrup FM, Aarestrup BJ. Atorvastatin and trans-caryophyllene for the prevention of leukopenia in an experimental chemotherapy model in Wistar rats. Mol Clin Oncol 2015; 3(4): 825-8.
198. Singla S, Sachdeva R, Mehta JL. Cannabinoids and atherosclerotic coronary heart disease. Clin Cardiol 2012; 35: 329-35.
199. Capettini LS, Savergnini SQ, da Silva RF, et al. Update on the role of cannabinoid receptors after ischemic stroke. Mediators Inflamm 2012; 2012: 824093.
200. Schmidt W, Schafer F, Striggow V, Frohlich K, Striggow F. Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia. Neuroscience 2012; 227: 313-26.
201. Fukuoka K, Sawabe A, Sugimoto T, et al. Inhibitory actions of several natural products on proliferation of rat vascular smooth muscle cells induced by Hsp60 from Chlamydia pneumoniae J138. J Agric Food Chem 2004; 52: 6326-9.
202. Sorkness RL. CAM and respiratory disease. Nutr Clin Pract 2009; 24: 609-15.
203. Seebaluck R, Gurib-Fakim A, Mahomoodally F. Medicinal plants from the genus Acalypha (Euphorbiaceae)--a review of their ethnopharmacology and phytochemistry. J Ethnopharmacol 2015; 159: 137-57.
204. Wu QF, Wang W, Dai XY, et al. Chemical compositions and antiinfluenza activities of essential oils from Mosla dianthera. J Ethnopharmacol 2012; 139: 668-71.
205. Shah AJ, Rasheed M, Jabeen Q, et al. Chemical analysis and calcium channel blocking activity of the essential oil of Perovskia abrotanoides. Nat Prod Commun 2013; 8: 1633-6.
206. Pinho-da-Silva L, Mendes-Maia PV, Teofilo TM, et al. trans-Caryophyllene, a natural sesquiterpene, causes tracheal smooth muscle relaxation through blockade of voltage-dependent Ca(2)(+) channels. Molecules 2012; 17(10): 11965-77.
207. Rogerio AP, Andrade EL, Leite DF, Figueiredo CP, Calixto JB. Preventive and therapeutic anti-inflammatory properties of the sesquiterpene alpha-humulene in experimental airways allergic inflammation. Br J Pharmacol 2009; 158(4): 1074-87.
208. Tang XJ, Huang HR, Fang TZ, et al. The antitussive and de-sputum essential substance from the root of Gerbera piloselloides and its analytical compositions. Zhongguo Zhong Yao Za Zhi 2003; 28: 426-9.
209. Miller AA, Budzyn K, Sobey CG. Vascular dysfunction in cerebrovascular disease: mechanisms and therapeutic intervention. Clin Sci (Lond) 2010; 119: 1-17.
210. Zhang L, Schuppan D. Traditional Chinese Medicine (TCM) for fibrotic liver disease: hope and hype. J Hepatol 2014; 61: 166-8.
211. Zhang Z, Guo Y, Zhang S, et al. Curcumin modulates cannabinoid receptors in liver fibrosis in vivo and inhibits extracellular matrix expression in hepatic stellate cells by suppressing cannabinoid receptor type-1 in vitro. Eur J Pharmacol 2013; 721: 133-40.
212. Mahmoud MF, Swefy SE, Hasan RA, Ibrahim A. Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats. Eur J Pharmacol 2014; 742: 118-24.
213. Teixeira-Clerc F, Julien B, Grenard P, et al. CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat Med 2006; 12: 671-6.
214. Pacher P, Gao B. Endocannabinoids and liver disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases. Am J Physiol Gastrointest Liver Physiol 2008; 294: G850-4.
215. Cho HI, Hong JM, Choi JW, et al. beta-Caryophyllene alleviates dgalactosamine and lipopolysaccharide-induced hepatic injury through suppression of the TLR4 and RAGE signaling pathways. Eur J Pharmacol 2015; 764: 613-21.
216. Yu M, Wang H, Ding A, et al. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 2006; 26(2): 174-9.
217. Nicolaidou E, Katsambas AD. Pigmentation disorders: hyperpigmentation and hypopigmentation. Clin Dermatol 2014; 32: 66-72.
218. Fisk WA, Agbai O, Lev-Tov HA, Sivamani RK. The use of botanically derived agents for hyperpigmentation: a systematic review. J Am Acad Dermatol 2014; 70: 352-65.
219. Kim HJ, Kim IS, Dong Y, et al. Melanogenesis-inducing effect of cirsimaritin through increases in microphthalmia-associated transcription factor and tyrosinase expression. Int J Mol Sci 2015; 16: 8772-88.
220. Yang CH, Huang YC, Tsai ML, et al. Inhibition of melanogenesis by beta-caryophyllene from lime mint essential oil in mouse B16 melanoma cells. Int J Cosmet Sci 2015; 37: 550-4.
221. Cornwell PA, Barry BW. Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil. J Pharm Pharmacol 1994; 46: 261-9.
222. Seow YX, Yeo CR, Chung HL, Yuk HG. Plant essential oils as active antimicrobial agents. Crit Rev Food Sci Nutr 2014; 54: 625-44.
223. Bernardes WA, Lucarini R, Tozatti MG, et al. Antibacterial activity of the essential oil from Rosmarinus officinalis and its major components against oral pathogens. Z Naturforsch C 2010; 65: 588-93.
224. Moon SE, Kim HY, Cha JD. Synergistic effect between clove oil and its major compounds and antibiotics against oral bacteria. Arch Oral Biol 2011; 56(9): 907-16.
225. Kim YS, Park SJ, Lee EJ, et al. Antibacterial compounds from Rose Bengal-sensitized photooxidation of beta-caryophyllene. J Food Sci 2008; 73(7): C540-5.
226. Schmidt E, Bail S, Friedl SM, et al. Antimicrobial activities of single aroma compounds. Nat Prod Commun 2010; 5: 1365-8.
227. Alma MH, Mavi A, Yildirim A, Digrak M, Hirata T. Screening chemical composition and in vitro antioxidant and antimicrobial activities of the essential oils from Origanum syriacum L. growing in Turkey. Biol Pharm Bull 2003; 26: 1725-9.
228. Lourens AC, Reddy D, Baser KH, Viljoen AM, Van Vuuren SF. In vitro biological activity and essential oil composition of four indigenous South African Helichrysum species. J Ethnopharmacol 2004; 95: 253-8.
229. Kamaraj C, Rahuman AA, Roopan SM, et al. Bioassay-guided isolation and characterization of active antiplasmodial compounds from Murraya koenigii extracts against Plasmodium falciparum and Plasmodium berghei. Parasitol Res 2014; 113: 1657-72.
230. Afoulous S, Ferhout H, Raoelison EG, et al. Chemical composition and anticancer, antiinflammatory, antioxidant and antimalarial activities of leaves essential oil of Cedrelopsis grevei. Food Chem Toxicol 2013; 56: 52-62.
231. Azeez S, Babu RO, Aykkal R, Narayanan R. Virtual screening and in vitro assay of potential drug like inhibitors from spices against glutathione-S-transferase of filarial nematodes. J Mol Model 2012; 18: 151-63.
232. Mansour SA, Messeha SS, el-Gengaihi SE. Botanical biocides. 4. Mosquitocidal activity of certain Thymus capitatus constituents. J Nat Toxins 2000; 9: 49-62.
233. Ali A, Tabanca N, Kurkcuoglu M, et al. Chemical composition, larvicidal, and biting deterrent activity of essential oils of two subspecies of Tanacetum argenteum (Asterales: Asteraceae) and individual constituents against Aedes aegypti (Diptera: Culicidae). J Med Entomol 2014; 51: 824-30.
234. da Silva RC, Milet-Pinheiro P, Bezerra da Silva PC, et al. (E)-Caryophyllene and alpha-Humulene: Aedes aegypti oviposition deterrents elucidated by gas chromatography-electrophysiological assay of Commiphora leptophloeos leaf oil. PLoS One 2015; 10(12): e0144586.
235. Govindarajan M, Rajeswary M, Hoti SL, Bhattacharyya A, Benelli G. Eugenol, alpha-pinene and beta-caryophyllene from Plectranthus barbatus essential oil as eco-friendly larvicides against malaria`, dengue and Japanese encephalitis mosquito vector. Parasitol Res 2015 Oct 31.
236. Ali A, Tabanca N, Demirci B, et al. Chemical composition and biological activity of four salvia essential oils and individual compounds against two species of mosquitoes. J Agric Food Chem 2015; 63(2): 447-56.
237. Papachristos DP, Karamanoli KI, Stamopoulos DC, Menkissoglu-Spiroudi U. The relationship between the chemical composition of three essential oils and their insecticidal activity against Acanthoscelides obtectus (Say). Pest Manag Sci 2004; 60: 514-20.
238. Holopainen JK, Gershenzon J. Multiple stress factors and the emission of plant VOCs. Trends Plant Sci 2010; 15: 176-84.
239. Zito P, Dotterl S, Sajeva M. Floral volatiles in a sapromyiophilous plant and their importance in attracting house fly pollinators. J Chem Ecol 2015; 41: 340-9.
240. Fantaye CA, Kopke D, Gershenzon J, Degenhardt J. Restoring (E)-beta-Caryophyllene Production in a Non-producing Maize Line Compromises its Resistance against the Fungus Colletotrichum graminicola. J Chem Ecol 2015; 41: 213-23.
241. Ruther J, Furstenau B. Emission of herbivore-induced volatiles in absence of a herbivore--response of Zea mays to green leaf volatiles and terpenoids. Z Naturforsch C 2005; 60: 743-56.
242. Kopke D, Beyaert I, Gershenzon J, Hilker M, Schmidt A. Speciesspecific responses of pine sesquiterpene synthases to sawfly oviposition. Phytochemistry 2010; 71: 909-17.
243. Shiojiri K, Ishizaki S, Ozawa R, Karban R. Airborne Signals of Communication in Sagebrush: A Pharmacological Approach. Plant Signal Behav 2015; 10(12): e1095416.
244. Fassotte B, Fischer C, Durieux D, Lognay G, Haubruge E, Francis F, Verheggen FJ. First evidence of a volatile sex pheromone in lady beetles. PLoS One 2014; 9: e115011.
245. Sato K, Takeuchi S. Chemical vapor detection using a reconstituted insect olfactory receptor complex. Angew Chem Int Ed Engl 2014; 53: 11798-802.
246. Tian BL, Liu QZ, Liu ZL, Li P, Wang JW. Insecticidal Potential of Clove Essential Oil and Its Constituents on Cacopsylla chinensis (Hemiptera: Psyllidae) in Laboratory and Field. J Econ Entomol 2015; 108(3): 957-61.
247. Ashitani T, Garboui SS, Schubert F, et al. Activity studies of sesquiterpene oxides and sulfides from the plant Hyptis suaveolens (Lamiaceae) and its repellency on Ixodes ricinus (Acari: Ixodidae). Exp Appl Acarol 2015; 67(4): 595-606.
248. Guo SS, You CX, Liang JY, et al. Chemical composition and bioactivities of the essential oil from etlingera yunnanensis against two stored product insects. Molecules 2015; 20(9): 15735-47.
249. Liu XC, Liu Q, Chen H, Liu QZ, Jiang SY, Liu ZL. Evaluation of contact toxicity and repellency of the essential oil of pogostemon cablin leaves and its constituents against blattella germanica (Blattodae: Blattelidae). J Med Entomol 2015; 52(1): 86-92.
250. Cárdenas-Ortega NC, González-Chávez MM, Figueroa-Brito R, et al. Composition of the Essential Oil of Salvia ballotiflora (Lamiaceae) and Its Insecticidal Activity. Molecules 2015; 20(5): 8048-59.
251. Elshafie HS, Mancini E, Sakr S, et al. Antifungal activity of some constituents of origanum vulgare l. essential oil against postharvest disease of peach fruit. J Med Food 2015; 18(8): 929-34.
252. Zhang WJ, You CX, Yang K, et al. Bioactivity of essential oil of Artemisia argyi Levl. et Van. and its main compounds against Lasioderma serricorne. J Oleo Sci 2014; 63: 829-37.
253. Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol 2011; 163: 1344-64.
254. Di Sotto A, Maffei F, Hrelia P, Castelli F, Sarpietro MG, Mazzanti G. Genotoxicity assessment of beta-caryophyllene oxide. Regul Toxicol Pharmacol 2013; 66: 264-8.
255. Di Sotto A, Mazzanti G, Carbone F, Hrelia P, Maffei F. Inhibition by beta-caryophyllene of ethyl methanesulfonate-induced clastogenicity in cultured human lymphocytes. Mutat Res 2010; 699(1-2): 23-8.
256. LaVoie EJ, Adams JD, Reinhardt J, Rivenson A, Hoffmann D. Toxicity studies on clove cigarette smoke and constituents of clove: determination of the LD50 of eugenol by intratracheal instillation in rats and hamsters. Arch Toxicol 1986; 59: 78-81.
257. Di Sotto A, Evandri MG, Mazzanti G. Antimutagenic and mutagenic activities of some terpenes in the bacterial reverse mutation assay. Mutat Res 2008; 653: 130-3.
258. Seifried HE, Seifried RM, Clarke JJ, Junghans TB, San RH. A compilation of two decades of mutagenicity test results with the Ames Salmonella typhimurium and L5178Y mouse lymphoma cell mutation assays. Chem Res Toxicol 2006; 19: 627-44.
259. Di Giacomo S, Mazzanti G, Di Sotto A. Mutagenicity of cigarette butt waste in the bacterial reverse mutation assay: The protective effects of beta-caryophyllene and beta-caryophyllene oxide. Environ Toxicol 2015.
260. Skipper PL, Kim MY, Sun HL, Wogan GN, Tannenbaum SR. Monocyclic aromatic amines as potential human carcinogens: old is new again. Carcinogenesis 2010; 31: 50-8.
261. Sarpietro MG, Di Sotto A, Accolla ML, Castelli F. Interaction of β-caryophyllene and β-caryophyllene oxide with phospholipid bilayers: Differential scanning calorimetry study. Thermochim Acta 2015; 600: 28-34.
262. Niki E, Yoshida Y, Saito Y, Noguchi N. Lipid peroxidation: Mechanisms, inhibition, and biological effects. Biochem Biophys Res Commun 2005; 338: 668-76.
263. Lima CS, de Medeiros BJ, Favacho HA, et al. Pre-clinical validation of a vaginal cream containing copaiba oil (reproductive toxicology study). Phytomedicine 2011; 18: 1013-23.
264. Poulopoulou I, Zoidis E, Massouras T, Hadjigeorgiou I. Terpenes transfer to milk and cheese after oral administration to sheep fed indoors. J Anim Physiol Anim Nutr (Berl) 2012; 96: 172-81.
265. Paulsen E, Andersen KE. Colophonium and Compositae mix as markers of fragrance allergy: cross-reactivity between fragrance terpenes, colophonium and compositae plant extracts. Contact Dermatitis 2005; 53: 285-91.
266. 2-cyclodextrin: Effect of interactions with water on complex stability. J Food Eng 2010; 99(1): 70-5.
267. Clericuzio M, Alagona G, Ghio C, Toma L. Ab initio and density functional evaluations of the molecular conformations of betacaryophyllene and 6-hydroxycaryophyllene. J Org Chem 2000; 65(21): 6910-6.
268. Sousa JP, Brancalion AP, Souza AB, et al. Validation of a gas chromatographic method to quantify sesquiterpenes in copaiba oils. J Pharm Biomed Anal 2011; 54: 653-9.
269. Gelmini F, Beretta G, Anselmi C, et al. GC-MS profiling of the phytochemical constituents of the oleoresin from Copaifera langsdorffii Desf. and a preliminary in vivo evaluation of its antipsoriatic effect. Int J Pharm 2013; 440: 170-8.
270. Patra KC, Singh B, Pareta S, Kumar KJ. A validated HPTLC method for determination of trans-caryophyllene from polyherbal formulations. Nat Prod Res 2010; 24: 1933-8.
271. Kalia YN, Naik A, Garrison J, Guy RH. Iontophoretic drug delivery. Adv Drug Deliv Rev 2004; 56: 619-58.
272. Williams AC, Barry BW. Essentail Oils as novel human skin penetration enhancers. Int J Pharm 1989; 721: R7-9.
273. Zhao K, Singh J. In vitro percutaneous absorption enhancement of propranolol hydrochloride through porcine epidermis by terpenes/ethanol. J Control Release 1999; 62: 359-66.
274. Akitoshi Y, Takayama K, Machida Y, Nagai T. Effect of cyclohexanone derivatives on percutaneous absorption of ketoprofen and indomethacin. Drug Des Deliv 1988; 2: 239-45.
275. Moghimi HR, Williams AC, Barry BW. A lamellar matrix model for stratum corneum intercellular lipids.1.Characterisation and comparison with stratum corneum intercellular structure. Int J Pharm 2015; 131(2): 103-15.
276. Akbari J, Saeedi M, Farzin D, Morteza-Semnani K, Esmaili Z. Transdermal absorption enhancing effect of the essential oil of Rosmarinus officinalis on percutaneous absorption of Na diclofenac from topical gel. Pharm Biol 2015; 53(10): 1442-7.
277. Bonan RF, Bonan PR, Batista AU, et al. In vitro antimicrobial activity of solution blow spun poly(lactic acid)/polyvinylpyrrolidone nanofibers loaded with Copaiba (Copaifera sp.) oil. Mater Sci Eng C Mater Biol Appl 2015; 48: 372-7.
278. O'Sullivan AJ, Crampton LJ, Freund J, Ho KK. The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women. J Clin Invest 1998; 102: 1035-40.
279. Zahir A, Kunta JR, Khan MA, Reddy IK. Effect of menthol on permeability of an optically active and racemic propranolol across guinea pig skin. Drug Dev Ind Pharm 1998; 24: 875-8.
280. Vaddi HK, Ho PC, Chan SY. Terpenes in propylene glycol as skinpenetration enhancers: permeation and partition of haloperidol, Fourier transform infrared spectroscopy, and differential scanning calorimetry. J Pharm Sci 2002; 91: 1639-51.
281. Vaddi HK, Ho PC, Chan YW, Chan SY. Terpenes in ethanol: haloperidol permeation and partition through human skin and stratum corneum changes. J Control Release 2002; 81: 121-33.